Your browser doesn't support javascript.
loading
Evolution of prevention of vertical HIV transmission in Uganda: 2008-2017.
Nahirney, Marissa; Grist, Jesse; Namasopo, Sophie; Brophy, Jason; Hawkes, Michael T.
Affiliation
  • Nahirney M; Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • Grist J; Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • Namasopo S; Kabale Regional Referral Hospital, Kabale, Uganda.
  • Brophy J; Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
  • Hawkes MT; Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
HIV Med ; 24(5): 605-615, 2023 05.
Article in En | MEDLINE | ID: mdl-36451299
ABSTRACT

OBJECTIVES:

Uganda adapted its policy for prevention of vertical transmission (VT) of HIV transmission as the World Health Organization released Options A, B and B+. We assessed trends in diagnostic testing, breastfeeding practices, maternal and infant antiretroviral therapy (ART), mortality, VT and HIV-free survival (HFS) among Ugandan infants born to women living with HIV during this period of successive guideline changes.

METHODS:

This is is a retrospective observational study of infants attending early infant diagnosis clinics at two Ugandan hospitals.

RESULTS:

A total of 1885 infants (48% female) were managed from 2009 to 2017. DNA polymerase chain reaction (PCR) for early infant diagnosis was performed on 1719 infants (92%, one or more PCR tests) and 676 infants (36%, two PCR tests). HIV serology was performed on 90 infants (4.8%). Testing increased over the study period but remained suboptimal, due to high loss to follow-up (LTFU). A total of 93% of infants were breastfed, for a median of 9.5 months. The duration of breast milk exposure increased over the study period, consistent with guidelines that increasingly encouraged breastfeeding. Nine cases (0.48%) of suspected breast milk transmission were observed. The use of ART increased significantly over the study period. Mortality (3.5%, 2.7% and 1.1%; p = 0.0076) and VT (17%, 12% and 7.4%; p < 0.0001) decreased over the study period (2008-2010, 2011-2012 and 2013-2017, respectively). LTFU values were 31%, 49% and 59% at 6, 12 and 18 months of age, respectively, with only modest improvements over time. HFS could only be conclusively documented in 532 infants (28%) because of LTFU.

CONCLUSIONS:

From 2009 to 2017, outcomes improved among HIV-exposed infants in Uganda. LTFU remains a barrier to optimal care.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Infectious / HIV Infections Type of study: Guideline / Observational_studies Limits: Female / Humans / Infant / Male / Pregnancy Country/Region as subject: Africa Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2023 Type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy Complications, Infectious / HIV Infections Type of study: Guideline / Observational_studies Limits: Female / Humans / Infant / Male / Pregnancy Country/Region as subject: Africa Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2023 Type: Article Affiliation country: Canada